| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 99.31M | — |
| Operating expense | — | — |
| Net income | -47.31M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IOVA returned +208.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +203.7% |
| 1 year | +208.2% |
| 5 years | -65.6% |
| 10 years | +4.1% |
| All-time high | $145.00 (Jun 2011) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IOVA would be worth today ›No. Iovance Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
Iovance Biotherapeutics, Inc. stock trades on NASDAQ under the ticker symbol IOVA.
Iovance Biotherapeutics, Inc. is part of the Healthcare sector.
Iovance Biotherapeutics, Inc. has a market cap of 3.76B USD, based on the latest quote.
Iovance Biotherapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
